Study of GLS-010 Injection in Patients With Recurrent or Metastatic Cervical Cancer
Clinical trial NCT03972722 · UNKNOWN
Trial details
- NCT number
- NCT03972722
- Sponsor
- Guangzhou Gloria Biosciences Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-15
- Primary completion
- 2022-05-15
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.